Levetiracetam attenuates experimental ulcerative colitis through promoting Nrf2/HO-1 antioxidant and inhibiting NF-κB, proinflammatory cytokines and iNOS/NO pathways
Keyvan Amirshahrokhi, Mahsa Imani
Topics & Concepts
LevetiracetamProinflammatory cytokineUlcerative colitisPharmacologyMyeloperoxidaseMedicineInflammatory bowel diseaseOxidative stressAntioxidantInflammationImmunologyChemistryInternal medicineBiochemistryEpilepsyDiseasePsychiatryGenomics, phytochemicals, and oxidative stressInflammatory Bowel DiseaseNF-κB Signaling Pathways